{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T19:58:15Z","timestamp":1775246295094,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.ejphar.2004.12.015","type":"journal-article","created":{"date-parts":[[2005,1,26]],"date-time":"2005-01-26T04:15:39Z","timestamp":1106712939000},"page":"37-42","source":"Crossref","is-referenced-by-count":34,"title":["Differentiation of opioid receptor preference by [Dmt1]endomorphin-2-mediated antinociception in the mouse"],"prefix":"10.1016","volume":"509","author":[{"given":"Yunden","family":"Jinsmaa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimitaka","family":"Shiotani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingyou","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Ambo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon D.","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence H.","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2004.12.015_bib1","doi-asserted-by":"crossref","first-page":"5556","DOI":"10.1021\/jm020336e","article-title":"Potent \u03b4-opioid receptor agonists containing the Dmt-Tic pharmacophore","volume":"45","author":"Balboni","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2004.12.015_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0006-8993(88)90962-6","article-title":"Role of mu 1-opiate receptors in supraspinal opiate analgesia: a microinjection study","volume":"447","author":"Bodnar","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2004.12.015_bib3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0165-6147(97)01156-5","article-title":"New \u03b4-opioid antagonists as pharmacological probes","volume":"19","author":"Bryant","year":"1998","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2004.12.015_bib4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/bip.10399","article-title":"Dmt and opioid peptides: a potent alliance","volume":"71","author":"Bryant","year":"2003","journal-title":"Biopolymers (Pept. Sci.)"},{"key":"10.1016\/j.ejphar.2004.12.015_bib5","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1021\/jm00094a002","article-title":"Analogs of the delta opioid receptor selective cyclic peptide [2-d-penicillamine,5-d-penicillamine]-enkephalin: 2\u2032,6\u2032-dimethyltyrosine and Gly3-Phe4 amide bond isostere substitutions","volume":"32","author":"Chandrakumar","year":"1992","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2004.12.015_bib6","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.2042-7158.1969.tb08312.x","article-title":"The effects of narcotics and narcotic antagonists on the tail-flick response in spinal mice","volume":"21","author":"Dewey","year":"1969","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.12.015_bib7","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1021\/jm030649p","article-title":"Development of potent bifunctional endomorphin-2 analogs with mixed \u03bc\/\u03b4-opioid agonist\/\u03b4-opioid antagonist properties","volume":"47","author":"Fujita","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2004.12.015_bib8","first-page":"1007","article-title":"Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain","volume":"286","author":"Goldberg","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.12.015_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0014-2999(96)00067-2","article-title":"Opioid receptor selectivity alteration by single residue replacement: synthesis and activity profile of [Dmt1]deltorphin B","volume":"302","author":"Guerrini","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.12.015_bib10","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1021\/jm00082a008","article-title":"Systemic analgesic activity and delta-opioid selectivity in [2,6-dimethyl-Tyr1, d-Pen2,d-Pen5]enkephalin","volume":"35","author":"Hansen","year":"1992","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2004.12.015_bib11","first-page":"238","article-title":"Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine","volume":"245","author":"Heyman","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.12.015_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.103.060061","article-title":"Novel 2\u2032,6\u2032-dimethyl-l-tyrosine-containing pyrazinone opioid mimetic \u03bc agonists with potent antinociceptive activity in mice","volume":"309","author":"Jinsmaa","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.12.015_bib13","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1021\/jm0304616","article-title":"Oral availability of a new class of \u03bc-opioid receptor agonists containing 3,6-bis-[Dmt-NH-(CH2)n]-2(1H)-pyrazinone with central mediated analgesia","volume":"47","author":"Jinsmaa","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2004.12.015_bib14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0160-5402(86)90038-0","article-title":"Intracerebroventricular injections in mice","volume":"16","author":"Laursen","year":"1986","journal-title":"J. Pharmacol. Methods"},{"key":"10.1016\/j.ejphar.2004.12.015_bib15","doi-asserted-by":"crossref","unstructured":"Li, T., Fujita, Y., Tsuda, Y., Miyazaki, A., Ambo, A., Sasaki, Y., Jinsmaa, Y., Bryant, S.D., Lazarus, L.H., Okada, Y., in press. Development of potent \u03bc-opioid receptor ligands using unique tyrosine analogues of endomorphin-2. J. Med. Chem.","DOI":"10.1021\/jm049384k"},{"key":"10.1016\/j.ejphar.2004.12.015_bib16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0006-8993(83)91376-8","article-title":"Spinal and supraspinal opioid analgesia in the mouse: the role of subpopulations of opioid binding sites","volume":"271","author":"Ling","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2004.12.015_bib18","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1248\/cpb.46.1374","article-title":"Amino acids and peptides. LII. Design and synthesis of opioid mimetics containing a pyrazinone ring and examination of their opioid receptor binding activity","volume":"46","author":"Okada","year":"1998","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ejphar.2004.12.015_bib19","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1248\/cpb.47.1193","article-title":"Synthesis of pyrazinone ring-containing opioid mimetics and examination of their opioid receptor binding activity","volume":"47","author":"Okada","year":"1999","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ejphar.2004.12.015_bib20","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1021\/jm020459z","article-title":"Unique high-affinity synthetic \u03bc-opioid receptor agonists with central- and systemic-mediated analgesia","volume":"46","author":"Okada","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2004.12.015_bib21","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/S0968-0896(03)00068-3","article-title":"Structural studies of [2\u2032,6\u2032-dimethyl-l-tyrosine1]endomorphin-2 analogues: enhanced activity and cis orientation of Dmt-Pro amide bond","volume":"11","author":"Okada","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2004.12.015_bib22","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/0024-3205(86)90217-1","article-title":"Multiple mu opiate receptors","volume":"38","author":"Pasternak","year":"1986","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2004.12.015_bib23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0014-2999(89)90792-9","article-title":"Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice","volume":"168","author":"Paul","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.12.015_bib24","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1021\/jm00033a005","article-title":"Enkephalin analogs as systemically active antinociceptive agents: O- and N-alkylated derivatives of the dipeptide amide l-2,6-dimethyltyrosyl-N-(3-phenylpropyl)-d-alaninamide","volume":"37","author":"Pitzele","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2004.12.015_bib25","first-page":"341","article-title":"Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse","volume":"230","author":"Porreca","year":"1984","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.12.015_bib26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0014-2999(88)90502-X","article-title":"Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist","volume":"146","author":"Portoghese","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.12.015_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0014-2999(99)00181-8","article-title":"Differential involvement of \u03bc-opioid receptor subtypes in endomorphin-1- and endomorphin-2-induced antinociception","volume":"372","author":"Sakurada","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.12.015_bib28","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/BF03401608","article-title":"\u03b4 Opioid mimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides","volume":"1","author":"Salvadori","year":"1995","journal-title":"Mol. Med."},{"key":"10.1016\/j.ejphar.2004.12.015_bib29","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1021\/jm9607663","article-title":"Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity","volume":"40","author":"Salvadori","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2004.12.015_bib30","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1021\/jm990165m","article-title":"Further studies on the Dmt-Tic pharmacophore: hydrophobic substituents at the C-terminus endow delta antagonists to manifest \u03bc agonism or \u03bc antagonism","volume":"42","author":"Salvadori","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2004.12.015_bib31","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1248\/cpb.47.1506","article-title":"Biological properties of opioid peptides replacing Tyr at position 1 by 2,6-dimethyl-Tyr","volume":"47","author":"Sasaki","year":"1999","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ejphar.2004.12.015_bib32","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/0024-3205(79)90403-X","article-title":"On the specificity of naloxone as an opiate antagonist","volume":"25","author":"Sawynok","year":"1979","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2004.12.015_bib33","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0223-5234(00)01171-5","article-title":"Synthesis and in vitro opioid activity profiles of DALDA analogues","volume":"35","author":"Schiller","year":"2000","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2004.12.015_bib34","first-page":"1","article-title":"In vivo studies on spinal opiate receptor systems mediating antinociception: II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat","volume":"228","author":"Schmauss","year":"1984","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.12.015_bib35","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1097\/00001756-199709290-00025","article-title":"Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2","volume":"8","author":"Stone","year":"1997","journal-title":"NeuroReport"},{"key":"10.1016\/j.ejphar.2004.12.015_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0006-8993(82)91029-0","article-title":"In vivo evidence for multiple opiate receptors mediating analgesia in the rat spinal cord","volume":"247","author":"Tung","year":"1982","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2004.12.015_bib37","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1073\/pnas.78.10.6181","article-title":"Classification of multiple morphine and enkephalin binding sites in the central nervous system","volume":"78","author":"Wolozin","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2004.12.015_bib39","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/386499a0","article-title":"A potent and selective endogenous agonist for the mu-opiate receptor","volume":"386","author":"Zadina","year":"1997","journal-title":"Nature"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299904014220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299904014220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T03:54:59Z","timestamp":1548820499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299904014220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0014299904014220"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2004.12.015","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}